STAT+: Pharmalittle: We’re reading about a lawsuit over lab tests for meds, a Bristol myeloma drug, and more

🇺🇸 STAT News Health (US) —
STAT+: Pharmalittle: We’re reading about a lawsuit over lab tests for meds, a Bristol myeloma drug, and more

AI Summary

The FDA has approved a new oral treatment from Bristol-Myers Squibb for advanced multiple myeloma, introducing a novel class of medication for this blood cancer. This marks a significant advancement in treatment options for patients with this condition.

The FDA approved a Bristol oral treatment for advanced multiple myeloma, marking the debut of a new class of medicine for the blood cancer

Markets Health AI & Tech FDA Bristol-Myers Squibb multiple myeloma oral treatment cancer medication healthcare innovation

Read original source →